GnRH Therapy on Cognition in Down Syndrome
Abroad (travel likely)RecruitingPHASE2, PHASE3
Conditions
Down Syndrome · Cognitive Decline · Alzheimer Disease, Early Onset · Olfaction Disorders
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Canton of Vaud, Switzerland
Contact: Principal Investigator (Nelly Pitteloud, MD)
Study leads
Nelly Pitteloud, MD
Principal Investigator
Endocrinology, Metabolism, Diabetology (CHUV)